India's first intranasal vaccine against Covid has began it's phase 2 trials. The vaccine is dropped into the nostril and it gradually slips into the respiratory tract, where the vaccine neutralizes the virus in the nostril itself and prevents it from penetrating into the respiratory tract.

‘The intranasal vaccine is dropped into the nostril of a person and it gradually slips into the respiratory tract. The vaccine neutralizes the virus in the nostril itself and prevents it from penetrating deep down into the respiratory tract.’

Kanpur is the only center in the state where intranasal vaccine trials against Covid are being done. 




As many as 30 volunteers including doctors, their family members and others have administered the first dose of the intranasal vaccine.
Another 20 people will be administered this vaccine over the next few days. The second dose of the vaccine will be administered after 28 days to the volunteers.
All the volunteers who were administered nasal vaccine are adults.
Principal investigator for intranasal Covid vaccine, Dr J.S. Kushwaha said that the doses of the vaccine administered to healthy volunteers in this phase of trial have been well tolerated and no serious adverse events have been reported. All the volunteers are under observation.
Advertisement
Those administered vaccines will now report after 28 days and the same procedure will be repeated.
Advertisement
"The intranasal vaccine is dropped into the nostril of a person and it gradually slips into the respiratory tract. The dosage of this vaccine is repeated after 28 days just like Covaxin, which is administered twice in the same time period. The vaccine is designed to neutralize the virus in the nostril itself and prevent it from penetrating deep down into the respiratory tract," he said.
Source-IANS